Home Français Menu


shopping cart icon

Job Board > Post-doctoral fellowship in COVID-19 Immunology - CHU Ste Justine

Post-doctoral fellowship in COVID-19 Immunology - CHU Ste Justine

Province: Montreal, Quebec
Position: Post-doctoral fellowship in COVID-19 Immunology
Deadline: December 31, 2021

Job Description / Duties

Dr. Decaluwe research is performed in an interdisciplinary setting with strong collaborations, and she is seeking one Immunologist for a 2/3-year Postdoctoral fellowship to contribute to granted COVID-19 related research projects on:
1) the possible reinfection of healthcare workers who contracted COVID-19 over a period of one year, as well as the study of the T response of these recovering patients who had or not been vaccinated with Pfizer-BioNTech or Moderna (RE-Infection in COVID-19 Estimation of Risk, RECOVER, CIHR funded project).
2) the study of the T response of children infected with SARS-CoV-2 over the course of a year (Persistence of T cell Immunity in Children with SARS-CoV-2 and Household contacts, PITCH, project funded by the CHAMO Innovation Fund).
3) the study of the T response of patients vaccinated with 4 to 7 products used in CANADA (funded by the COVID-19 Immunity Task Force, CITF).
4) the relationship between the SARS-CoV-2 epitope-associated mutational landscape and T cell responses in COVID-19 patients (Deciphering the immunopeptidomic landscape of COVID-19 disease, CIHR funded project).
The applicants’ interests and experience will be considered to determine the exact projects that he will undertake.

Qualifications / Required Skills

The ideal candidate must have a PhD in immunology. He/she must be highly motivated, pro-active, and autonomous, with great scientific rigor, and excellent organizational skills, and be able to work independently within a very collaborative environment. He/she must be result- driven, be able to manage several experiments head-on, actively participate in the laboratory activities in a collegiate way, work in collaboration with one junior PhD student and occasionally supervise junior students or trainees and collaborate to the laboratory's grant applications. He/she must have a very good team spirit, be proficient in written and oral English and be an excellent communicator. His/her knowledge of French is an asset but is not necessary. He/she must have demonstrated significant scientific contributions and published in high impact journals. He/she must have a solid expertise in multiparametric flow cytometry and cell culture.

Additional Information

The selected candidate will join Dr. Decaluwe's team at the CHU Sainte-Justine and work within the Research Center.
1 year contract, renewed according to the progress and needs of the project.
The remuneration is based on the experience of the candidate.

Salary: The remuneration is based on the experience of the candidate.

Contact Information

Submit your application
Interested candidates must submit the following documentation to Hélène Decaluwe at helene.decaluwe@umontreal.ca.

√ Curriculum vitae
√ Transcripts
√ Statement of research background and interest
√ Two reference letters including from prior PhD mentor

Dr Hélène Decaluwe, MD, PhD, FRCPC
Service d'immunologie et rhumatologie pédiatrique
Centre de recherche du CHU Sainte-Justine
3175, chemin de la Côte Sainte-Catherine
H3T 1C5, Montréal (Québec), Canada
Tél bureau: (514) 345-4713
Tél labo: (514)345-4931, poste 2248
Fax: (514) 345-4897
Email: helene.decaluwe@umontreal.ca

Employer Profile

Dr. Hélène Decaluwe is a clinical researcher at the CHU Sainte-Justine and her laboratory's research mainly focuses on the role of cytokines and their signaling pathways in the regulation of CD8 T lymphocyte responses during chronic viral infection or cancer. In the context of the current COVID-19 pandemic, her laboratory has developed expertise to study the response of T lymphocytes to Sars-CoV-2 and has been involved in the Canadian response to the pandemic, advising the COVID-19 Immunity Task Force (CITF) leadership on immune science priorities related to the COVID-19 pandemic and working intensively into harmonizing and providing cell-mediated immune assays across funded Canadian COVID-19 seroprevalence studies.